256 results on '"Trachtenberg, Barry H."'
Search Results
2. Contributors
3. Targeted treatments of AL and ATTR amyloidosis
4. Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study
5. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study
6. Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy
7. A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis
8. Association between digoxin use and gastrointestinal bleeding in contemporary continuous flow left ventricular assist device support
9. A principal components analysis of factors associated with successful implementation of an LVAD decision support tool
10. Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
11. Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
12. Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
13. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives
14. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial
15. Acquired and Hereditary Hypercoagulable States in Patients with Continuous Flow Left Ventricular Assist Devices: Prevalence and Thrombotic Complications
16. Persistent Blood Stream Infection in Patients Supported With a Continuous-Flow Left Ventricular Assist Device Is Associated With an Increased Risk of Cerebrovascular Accidents
17. Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
18. A simplified echocardiographic technique for detecting continuous-flow left ventricular assist device malfunction due to pump thrombosis
19. 6 - Surgical risks
20. Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart Transplantation
21. Genetic Architecture of Dilated Cardiomyopathy in Individuals of African and European Ancestry.
22. Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure
23. Roads, Maps, and Destinations: the Journey of Left Ventricular Assist Device Implantation in Ambulatory Patients with Advanced Heart Failure
24. Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation
25. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study
26. Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device
27. Melding a High-Risk Patient for Continuous Flow Left Ventricular Assist Device into a Low-Risk Patient
28. Inflammatory Cardiomyopathic Syndromes
29. Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial.
30. Validating an Idiopathic Dilated Cardiomyopathy Diagnosis Using Cardiovascular Magnetic Resonance: The Dilated Cardiomyopathy Precision Medicine Study
31. Targeted treatments of AL and ATTR amyloidosis
32. Presence of the V122I Variant of Hereditary Transthyretin-Mediated Amyloidosis Among Self-Reported White Individuals in a Sponsored Genetic Testing Program
33. Effectiveness of the Family Heart TalkCommunication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial
34. Biomarkers of Oxidative Stress in Heart Failure
35. Additional file 1 of Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
36. Additional file 2 of Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
37. Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer
38. Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial
39. Defining Vasoplegia Following Durable, Continuous Flow Left Ventricular Assist Device Implantation
40. Baseline Global Longitudinal Strain Predictive of Anthracycline-Induced Cardiotoxicity
41. Contributors
42. Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis
43. Safety of serial MRI in patients with implantable cardioverter defibrillators
44. Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
45. A Principal Components Analysis of Factors Associated with Successful Implementation of an LVAD Decision Support Tool
46. Shared Decision Making In Cardiology Practice: 15 Month Results of A Multi-Site Study of Decision Aid Implementation
47. Baseline Global Longitudinal Strain Predictive of Anthracycline-Induced Cardiotoxicity
48. Should We Be for ASCT?
49. A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis
50. Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.